Skip to main content

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK (

TheStreet

) --

CHANGE IN RATINGS

Archer Daniels Midland

(ADM) - Get Archer-Daniels-Midland Company Report

downgraded at Credit Suisse to Neutral from Outperform. Largely a valuation call but also corn sweetener pricing power and buyback issues already played out, Credit Suisse said. Maintain $37 price target.

Allstate

(ALL) - Get Allstate Corporation Report

downgraded at Argus from Buy to Hold, Argus Research said. Valuation call.

Ariba

( ARBA) downgraded at JMP from Outperform to Market Perform. Valuation call, as the stock is up more than 50% year-to-date.

Cardinal Health

(CAH) - Get Cardinal Health, Inc. Report

upgraded at Baird from Neutral to Outperform, Robert Baird said. $41 price target. Recent quarter was an inflection point for the company, which will likely exceed 2011 expectations.

TheStreet Recommends

Corn Products International

( CPO) upgraded at Citi to Buy from Hold as acquisition of National Starch is a game changer. Price target goes to $51 from $44.

Expedia

(EXPE) - Get Expedia Group, Inc. Report

downgraded at Citi to Hold from Buy. Strong 3Q but valuation leads to downgrade, Citigroup said. Price target raised to $34 from $28.

Expedia

(EXPE) - Get Expedia Group, Inc. Report

downgraded at Piper to Neutral, Piper Jaffray said. Valuation call, based on a $30 price target.

First Solar

(FSLR) - Get First Solar, Inc. Report

downgraded at Deutsche to Hold, Deutsche Bank said. $125 price target. Company is facing potential growth headwinds in 2011.

First Solar

(FSLR) - Get First Solar, Inc. Report

estimate cut at Barclays. FSLR 2010 EPS estimate lowered to $7.55, 2011 held at $8.55. Beat and raise not enough, Barclays said. Maintain Equal Weight rating and $140 price target.

Starwood Hotels

(HOT)

downgraded at Baird from Neutral to Underperform, Robert Baird said. $45 price target. Valuation call, as the stock is already pricing in moderate earnings growth.

KLA Tenor

(KLAC) - Get KLA Corporation Report

downgraded at Citi to Sell from Hold. Back-end order cliff trumps big KLAC orders. Maintain $30 price target.

KLA Tencor

(KLAC) - Get KLA Corporation Report

price target boosted at Credit Suisse to $44 from $35. Earnings power remains intact, valuation attractive. Maintain Outperform rating.

MDU Resources

(MDU) - Get MDU Resources Group Inc Report

downgraded at Baird from Outperform to Neutral. $23 price target. Company lacks near-term catalysts.

Morgan Stanley

(MS) - Get Morgan Stanley Report

upgraded at Ticonderoga to Buy from Neutral. Company should benefit from a cyclical market recovery.

Monster Worldwide

(MWW)

upgraded at Citi to Buy from Hold on solid 3Q results and strong outlook, Citigroup said. Price target lifted to $221 from $17.

Maxim Integrated

(MXIM) - Get Maxim Integrated Products, Inc. Report

upgraded at FBR from Market Perform to Outperform. $29 price target. Estimates also boosted, to match the company's new guidance.

Nuvasive

(NUVA) - Get NuVasive, Inc. Report

estimates, target lowered at Goldman. Shares of NUVA now seen reaching $24. Estimates also cut, given slowing market growth and increased competition in spinal implants. Neutral rating.

Nuvasive

(NUVA) - Get NuVasive, Inc. Report

downgraded at William Blair to Market Perform. Estimates also cut, as the company cut guidance for the first time since its IPO.

Royal Caribbean

(RCL) - Get Royal Caribbean Group Report

upgraded at Argus from Hold to Buy. $53 price target. Company should see better demand and pricing for cruises.

Zimmer

(ZMH)

downgraded at UBS from Buy to Neutral, UBS said. $54 price target. Estimates also cut, as the company is seeing lower volumes.

Zimmer

(ZMH)

downgraded at Jefferies from Buy to Hold, Jefferies said. Orthopedic market remains challenged. $54 price target.

This article was written by a staff member of TheStreet.